Abstract
In 1990 Tuerk and Gold introduced the first RNA aptamer for bacteriophage T4 DNA polymerase, obtained by a new combinatorial technique which they designated as SELEX (systematic evolution of ligands by exponential enrichment). In parallel, ELLINGTON and Szostak (1990) showed that it is also possible to select RNA aptamers which are able to specifically complex organic molecules of low molecular weight, thus serving as receptor molecules based on nucleic acids rather than proteins. Since then, considerable progress has been achieved in the field of in vitro selection of combinatorial nucleic acid libraries, which demonstrates its impressive potential as a tool in molecular biology, diagnostics, molecular medicine, drug discovery, and bio-organic chemistry. Today, the SELEX process has been applied to more than a hundred different target molecules, and aptamers are known for almost every kind of targets such as organic dyes, amino acids, biological cofactors, antibiotics, peptides and proteins or even whole viruses (Bell et al. 1998; Gal et al. 1998; Ellington and Osborne 1997; Kraus et al. 1998; Yang et al. 1998; Eaton 1997; Pan et al. 1995), showing that aptamers can be obtained for almost any desired target whether complex or small.
Chapter PDF
Similar content being viewed by others
Keywords
- Human Immunodeficiency Virus Type
- Keratinocyte Growth Factor
- Rous Sarcoma Virus
- Human Neutrophil Elastase
- Human Keratinocyte Growth Factor
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Allen P, Worland S, Gold L (1995) Isolation of high-affinity RNA ligands to HIV-I integrase from a random pool. Virology 209: 327–336
Bell SD, Denus JM, Dixon JE, Ellington AD (1998) RNA molecules that bind to and inhibit the active site of a tyrosine phosphatase. J Biol Chem 273: 14309–14314
Bevilacqua MP, Nelson RM (1993) Selectins. J Clin Invest 91: 379–387
Bevilacqua MP, Nelson RM, Mannori G, Cecconi O (1994) Endothelial-Leukocyte adhesion molecules in human disease. Annu Rev Med 45: 361–378
Bless NM, Ward PA (1997) Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr Biol 7: 877–880
Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ (1992) Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355: 564–566
Brauchle M, Madlener M, Wagner AD, Angermeyer K, Lauer U, Hofschneider PH (1996) Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol 149: 521–529
Bridonneau P, Chang YF, O’Connell D, Gill SC, Snyder DW, Johnson L, Goodson TJ, Herron DK, Parma DH (1998) High-affinity aptamers selectively inhibit human nonpancreatic secretory phospholipase A2 (hnsp-PLA2). J Med Chem 41: 778–786
Buckanovich RJ, Darnell RB (1997) The neuronal RNA binding protein NOVA-1 recognises specific RNA targets in vitro and in vivo. Mol Cell Biol 17: 3194–3201
Buckanovich RJ, Yang YY, Darnell RB (1996) The onconeural antigen Nova-1 is a neuron-specific RNA binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci 16: 1114–1122
Charlton J, Kirschenheuter GP, Smith D (1997) Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library. Biochemistry 36: 3018–3026
Charlton J, Sennello J, Smith D (1997) In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 4: 809–816
Dagleish AG, Beverly PCL, Clapham PR, Crawford MF, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763
DeAnda JA, Coutre SE, Moon MR, Vial CM, Griffin LC, Law VS, Komeda M, Leung LLK, Miller DC (1994) Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. Ann Thorac Surg 58: 344–350
Doring G (1994) The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 150: 114–117
Doudna JA, Cech TR, Sullenger BA (1995) Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor. Proc Natl Acad Sci USA 92: 2355–2359
Eaton BE (1997) The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein argets. Curr Opin Chem Biol 1: 10–16
Edwards P, Bernstein P (1994) Synthetic inhibitors of elastase. Med Res Rev 14: 127–194
Ellington AD, Szostak JW (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346: 818–822
Esmon CT, Owen WG (1981) Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78: 2249–2252
Farrar MA, Schreiber RD (1993) The molecular cell biology of interferon-7 and its receptors. Annu Rev Immunol 11: 571
Finch PW, Pricolo V, Wu A, Finkelstein SD (1996) Increased expression of keratinocyte growth factor essenger RNA associated with inflammatory bowel disease. Gastroenterology 110: 441–451
Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA (1989) Human KGF is FGF-related with properties f a paracrine effector of epithelial cell growth. Science 244: 752–755
Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235: 442–447
Gal SW, Amontov S, Urvil PT, Vishnuvardhan D, Nishikawa F, Kumar PKR, Nishikawa S (1998) Selection of a RNA aptamer that binds to human activated protein C and inhibits its protease function. Eur J Biochem 252: 553–562
Giver I, Bartel DP, Zapp ML, Green MR, Ellington AD (1993) Selection and design of high-affinity RNA ligands for HIV-1 Rev. Gene 137: 19–24
Gold L, Polisky B, Uhlenbeck O, Yarns M (1995) Diversity of oligonucleotide functions. Annu rev Biochem 64: 763–797
Goldman MB, Robertson GL, Luchins DJ, Hedecker D, Pandey GN (1997) Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 54: 443–449
Gospodarowitz D (1991) Fibroblast growth factors: from genes to clinical applications. Cell Biol Rev 25: 307–314
Green LS, Jellinek D, Bell C, Beebe LA, Feistner BD, Gill SC, Jucker FM, Janjic N (1995) Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chemistry 00000 Biology 2: 683–695
Green LS, Jellinek D, Jenison R, Stman A, Heldin CH, Janjic N (1996) Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 35: 14413–14424
Haller AA, Sarnow P (1997) In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci USA 94: 8521–8526
Iida H, Seifert R, Alpers CE, Gronwald RGK, Phillips PE, Pritzl P, Gordon K, Gown AM, Ross R, Bowen-Pope DF, Johnson RJ (1991) Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferation nephritis in the rat. Proc Natl Acad Sci USA 88: 6560–6564
Ishii H, Hattori Y, Itoh H, Kishi T, Yoshida T, Sakamoto H (1994) Preferential expression of the third immunoglobulin-like domain of k-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines. Cancer Res 54: 518–522
Jellinek D, Green LS, Bell C, Lynott CK, Gill N, Vargeese C, Kirschenheuter G, McGee DP, Abesinghe P, Pieken WA, et al. (1995) Potent 2’-amino-2’-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34: 11363–11372
Jellinek D, Lynott CK, Rifkin DB, Janjic N (1993) High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci USA 90: 11227–11231
Klußmann S, Nolte A, Bald R, Erdmann VA, Fürste JP (1996) Mirror-image RNA that binds D-adenosine. Nat Biotechnol 14: 1112–1115
Kraus E, James W, Barclay AN (1998) Cutting edge: Novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J Immunology 160: 5209–5212
Kubik MF, Bell C, Fitzwater T, Watson SR, Tasset DM (1997) Isolation and characterization of 2’-fluoro-, 2’-amino-, and 2’-fluoro-/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding. J Immunol 159: 259–267
Kubik MF, Stephens AW, Schneider D, Marlar RA, Tasset D (1994) High-affinity RNA ligands to human alpha-thrombin. Nucleic Acids Res 22: 2619–2626
Labrie F (1990) Hormones from molecules to diseases, E. E. Baulieu and P. A. Kelly, eds. (New York, N.Y.: Herman Publisher).
Latham JA, Johnson R, Toole JJ (1994) The application of a modified nucleotide in aptamer selection: ovel thrombin aptamers containing 5-(1-pentynyl)-2’-deoxyuridine. Nucleic Acids Res 22: 2817–2822
Lee PP, Ramanathan M, Hunt CA, Garovoy MR (1996) An oligonucleotide blocks interferon-gamma ignal transduction. Transplantation 62: 1297–1301
Lee SW, Sullenger BA (1997) Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nature Biotechnology 15: 41–45
Li WX, Kaplan AV, Grant GW, Toole JJ, Leung LLK (1994) A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation. Blood 83: 677–682
Lin Y, Nieuwlandt D, Magallanez A, Feistner B, Jayasena SD (1996) High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro selected 2’-amino-modified RNA. Nucleic Acid Research 24: 3407–3414
Lindner V, Giachelli CM, Schwartz SM, Reidy MA (1995) A subpopulation of smooth muscle cells in njured rat arteries expresses platelet-derived growth factor-B chain mRNA. Circ Res 76: 951–957
Lindner V, Reidy MA (1995) Platelet-Derived growth factor ligand and receptor expression by large essel endothelium in vivo. Am J Pathol 146: 1488–1497
Lindstrom J, Shelton D, Fujii Y (1988) Myasthenia gravis. Advances in Immunology 42: 233–284
Moscatelli D (1987) High and low affinity sites from basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 131: 123–130
Nielsen S, Chou CL, Marples D, Christensen EI, Kishore BK, Knepper MA (1995) Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci USA 92: 1013–1017
Nolte A, KluBmann S, Bald R, Erdmann VA, Fürste JP (1996) Mirror-design of L-oligonucleotide ligands binding to L-arginine. Nat Biotechnol 14: 1116–1119
O’Connell D, Koenig A, Jennings S, Hicke B, Han HL, Fitzwater T, Chang YF, Varki N, Parma D, Varki A (1996) Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc Natl Acad Sci USA 93: 5883–5887
Oleksyszyn J, Powers J (1991) Irreversible inhibition of serine proteases by peptide derivatives of (alphaaminoalkylphosphonate)diphenyl ester. Biochemistry 30: 485–493
Osborne SE, Ellington AD (1997) Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev 97: 349–370
Pagratis NC, Bell C, Chang Y-F, Jennings S, Fitzwater T, Jellinek D, Dang C (1997) Potent 2’-amino-, and 2’-fluoro-2’-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nature Biotechnology 15: 68–73
Pan W, Craven RC, Qiu Q, Wilson CB, Wills JW, Golovine S, Wang JF (1995) Isolation of virusneutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci USA 92: 11509–1513
Pierce JG, Parsons IF (1981) Glycoprotein hormones: structure and function. Annu Rev Biochem 50: 465–495
Repine J (1992) Scientific perspectives on adult respiratory distress syndrome. Lancet 339: 466–469
Reynolds RJ, Hughes LL, Denis EA (1992) Analysis of human synovial fluid phospholipase A2 on short hain phosphatidylcholine-mixed micelles: development of a spectrophotometric assay suitable for a icrotiterplate reader. Anal Biochem 204: 190–197
Rintala EM, Nevalainen TJ (1993) Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections. Clin Infect Disease 17: 864–870
Rubin JS, Osada H, Finch RW, Taylor WG, Rudikoff S, Aaronson SA (1989) Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802–806
Schevitz RW, Bach NJ, Carlson DG, Chirgadze NY, Clawson DK, Dillard RD, Draheim SE, Hartley LW, Jones ND, Mihelich ED, Olkowski JL, Snyder DW, Sommers C, Wery JP (1995) Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nature Struct Biol 2: 458–465
Schneider DJ, Feigon J, Hostomsky Z, Gold L (1995) High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34: 9599–9610
Smith D, Kirschenheuter GP, Charlton J, Guidot DM, Repine JE (1995) In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chemistry 00000 Biology 2: 741–750
Snyder DW, Sommers CD, Bobbitt JL, Mihelich ED (1993) Characterization of the contractile effects of human recombinant non-pancreatic secretory phospholipase A2 and other PLA2 s on guinea pig lung pleural-strips. J Pharmacol Exp Ther 266:1147–1155
Staiano-Coico L, Krueger JG, Rubin JS, D’limi S, Vallat VP, Valentino L (1993) Human keratinocyte rowth factor effect in a porcine model of epidermal wound healing. J Ex Med 178: 865–878
Symensma TL, Giver L, Zapp M, Takle GB, Ellington AD (1996) RNA aptamers selected to bind human mmunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J Virol 70: 179–187
Trinchieri G, Perussia B (1985) Immune interferon: a pleiotropic lymphokine with multiple effects. mmunology Today 6: 131
Tuerk C, Gold L (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249: 505–510
Tuerk C, MacDougal S, Gold L (1992) RNA pseudoknots that inhibit human immunodeficiency virus type I reverse transcriptase. Proc Natl Acad Sci USA 89: 6988–6992
Wiegand TW, Williams PB, Dreskin SC, Jouvin MH, Kinet JP, Tasset D (1996) High-affinity oligonu cleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol 157: 221–230
Williams KP, Liu XH, Schumacher TN, Lin HY, Ausiello DA, Kim PS, Bartel DP (1997) Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci USA 94: 11285–11290
Yang Q, Goldstein IJ, Mei HY, Engelke DR (1998) DNA ligands that bind tightly and selectively to cellobiose. Proc Natl Acad Sci USA 95: 5462–5467
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Famulok, M., Mayer, G. (1999). Aptamers as Tools in Molecular Biology and Immunology. In: Famulok, M., Winnacker, EL., Wong, CH. (eds) Combinatorial Chemistry in Biology. Current Topics in Microbiology and Immunology, vol 243. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60142-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-60142-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64274-6
Online ISBN: 978-3-642-60142-2
eBook Packages: Springer Book Archive